Clinical Trials Directory

Trials / Completed

CompletedNCT06303219

Effects of Traditional Moderate Intensity Training and High Intensity Interval Training in Polycystic Ovarian Syndrome

Comparative Effects of Traditional Moderate Intensity Training and High Intensity Interval Training on Anxiety, Fatigue and Quality of Life in Polycystic Ovarian Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Riphah International University · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

To determine the comparative effects of traditional moderate intensity training and high intensity interval training on Anxiety, fatigue and Quality of Life in females with polycystic ovarian syndrome

Conditions

Interventions

TypeNameDescription
OTHERRADITIONAL MODERATE INTENSITY TRAININGIt consists of patients who will receive High-intensity interval training, including running as well as walking at 80% to 95% HR peak. Which is monitored by a smart watch. Before starting treatment, it follows a 10-minute warm-up exercise which includes basic stretches (Quads, Hams, and calf muscles) with a 30-second hold of both legs and same exercise will be pursued for the cool-down period. This intervention will be performed 5 days per week for 4 weeks. The total duration of this session will be 50 minutes
OTHERHIGH INTENSITY INTERVAL TRAININGIt consists of patients who will receive Moderate-intensity interval training, including running as well as walking at 60% HR peak. Which is monitored by a smart watch. Before starting treatment, it follows a 10-minute warm-up exercise which includes basic stretches (Quads, Hams, and calf muscles) with a 30-second hold of both legs and same exercise will be pursued for the cool-down period. This intervention will be performed 5 days per week for 4 weeks. The total duration of this session will be 50 minutes (

Timeline

Start date
2023-11-23
Primary completion
2024-08-01
Completion
2024-08-19
First posted
2024-03-12
Last updated
2024-09-04

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06303219. Inclusion in this directory is not an endorsement.